ROBAXISAL C 1/2
GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is ROBAXISAL C 1/2 discontinued in Canada?
Yes. The manufacturer has reported to Health Canada that ROBAXISAL C 1/2 325MG 32.4MG 400MG has been permanently discontinued (last updated March 2, 2026). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.
Why is ROBAXISAL C 1/2 not available?
The reason the manufacturer reported: Business reasons.
What this means
Does this mean I need to switch medications right away?
Not necessarily right away, but this product will not be returning to the market.
What should I do?
Talk to your pharmacist or prescriber about your options well before your current supply runs out.
DIN
01934791
Strength
325MG 32.4MG 400MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
ACETYLSALICYLIC ACID CODEINE PHOSPHATE METHOCARBAMOL
Tier
Unrated
Last Updated
2026-03-02
Reason for Shortage
Business reasons
Past Reports for This Drug
ROBAXISAL C 1/2 has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from GLAXOSMITHKLINE CONSUMER HEALTHCARE ULC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.